Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer Discovery
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Cancer Discov 2024 Nov 01;14(11)2135-2161, J Dilly, MT Hoffman, L Abbassi, Z Li, F Paradiso, BD Parent, CJ Hennessey, AC Jordan, M Morgado, S Dasgupta, GA Uribe, A Yang, KS Kapner, FP Hambitzer, L Qiang, H Feng, J Geisberg, J Wang, KE Evans, H Lyu, A Schalck, N Feng, AM Lopez, CA Bristow, MP Kim, KI Rajapakshe, V Bahrambeigi, JA Roth, K Garg, PA Guerrero, BZ Stanger, S Cristea, SW Lowe, T Baslan, EM Van Allen, JD Mancias, E Chan, A Anderson, YV Katlinskaya, AK Shalek, DS Hong, S Pant, J Hallin, K Anderes, P Olson, TP Heffernan, S Chugh, JG Christensen, A Maitra, BM Wolpin, S Raghavan, JA Nowak, PS Winter, SK Dougan, AJ AguirreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.